These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 39069612)

  • 21. Dendritic Cell Metabolism and Function in Tumors.
    Giovanelli P; Sandoval TA; Cubillos-Ruiz JR
    Trends Immunol; 2019 Aug; 40(8):699-718. PubMed ID: 31301952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy.
    Zhou J; Ma X; Liu X; Liu Y; Fu J; Qi Y; Liu H
    Genes Genomics; 2024 Sep; 46(9):991-1011. PubMed ID: 39127851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid metabolic reprogramming in the tumor microenvironment and its implication for cancer therapy.
    Zhang J; Chen M; Yang Y; Liu Z; Guo W; Xiang P; Zeng Z; Wang D; Xiong W
    J Cell Physiol; 2024 Nov; 239(11):e31349. PubMed ID: 38946173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
    Huang L; Xu H; Peng G
    Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment.
    Keerthana CK; Rayginia TP; Shifana SC; Anto NP; Kalimuthu K; Isakov N; Anto RJ
    Front Immunol; 2023; 14():1114582. PubMed ID: 36875093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMPK-a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?
    Wang N; Wang B; Maswikiti EP; Yu Y; Song K; Ma C; Han X; Ma H; Deng X; Yu R; Chen H
    Cell Death Discov; 2024 May; 10(1):237. PubMed ID: 38762523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment.
    Mafi S; Mansoori B; Taeb S; Sadeghi H; Abbasi R; Cho WC; Rostamzadeh D
    Front Immunol; 2021; 12():774103. PubMed ID: 35250965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
    Li J; Lu Z; Zhang Y; Xia L; Su Z
    Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
    Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
    Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in reprogramming of energy metabolism in tumor T cells.
    Xuekai L; Yan S; Jian C; Yifei S; Xinyue W; Wenyuan Z; Shuwen H; Xi Y
    Front Immunol; 2024; 15():1347181. PubMed ID: 38415258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic reprogramming in the tumor microenvironment of liver cancer.
    Lin J; Rao D; Zhang M; Gao Q
    J Hematol Oncol; 2024 Jan; 17(1):6. PubMed ID: 38297372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses.
    Huldani H; Malviya J; Rodrigues P; Hjazi A; Deorari MM; Al-Hetty HRAK; Qasim QA; Alasheqi MQ; Ihsan A
    Cell Biochem Funct; 2024 Mar; 42(2):e3934. PubMed ID: 38379261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
    Nachef M; Ali AK; Almutairi SM; Lee SH
    Front Immunol; 2021; 12():624324. PubMed ID: 33953707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment.
    Zhang H; Li S; Wang D; Liu S; Xiao T; Gu W; Yang H; Wang H; Yang M; Chen P
    Biomark Res; 2024 Sep; 12(1):96. PubMed ID: 39227970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid metabolism in tumor: New shine in the fog?
    Qiu H; Shao N; Liu J; Zhao J; Chen C; Li Q; He Z; Zhao X; Xu L
    Clin Nutr; 2023 Aug; 42(8):1521-1530. PubMed ID: 37321900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cancer metabolic reprogramming and immune response.
    Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
    Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review.
    Wang D; Wan X
    Biomed Pharmacother; 2022 Dec; 156():113923. PubMed ID: 36411616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.
    Wang J; Zhang W; Liu C; Wang L; Wu J; Sun C; Wu Q
    Int J Biol Sci; 2024; 20(5):1884-1904. PubMed ID: 38481820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tumor Microenvironment: Signal Transduction.
    Zhang X; Ma H; Gao Y; Liang Y; Du Y; Hao S; Ni T
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.